Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized Therapy

Lung cancer first line treatment has been directed from the non-specific cytotoxic doublet chemotherapy to the molecular targeted. The major limitation of the targeted therapies still remains the small number of patients positive to gene mutations. Furthermore, the differentiation between second lin...

Descripción completa

Detalles Bibliográficos
Autores principales: Domvri, Kalliopi, Zarogoulidis, Paul, Darwiche, Kaid, Browning, Robert F., Li, Qiang, Turner, J. Francis, Kioumis, Ioannis, Spyratos, Dionysios, Porpodis, Konstantinos, Papaiwannou, Antonis, Tsiouda, Theodora, Freitag, Lutz, Zarogoulidis, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842443/
https://www.ncbi.nlm.nih.gov/pubmed/24312144
http://dx.doi.org/10.7150/jca.7734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842443/
https://www.ncbi.nlm.nih.gov/pubmed/24312144
http://dx.doi.org/10.7150/jca.7734

Ejemplares similares